CD40Ig treatment results in allograft acceptance mediated by CD8+CD45RClow T cells, IFN-γ, and indoleamine 2,3-dioxygenase

Journal of Clinical Investigation

Volumn 117, Issue 4, 2007, Pages 1096-1106

  Guillonneau, Carole ^a   Hill, Marcelo ^a   Hubert, François Xavier ^a   Chiffoleau, Elise ^a   Hervé, Caroline ^a   Li, Xian Liang ^a   Heslan, Michèle ^a   Usal, Claire ^a   Tesson, Laurent ^a   Ménoret, Séverine ^a   Saoudi, Abdelhadi ^b   Le Mauff, Brigitte ^a   Josien, Régis ^a   Cuturi, Maria Cristina ^a   Anegon, Ignacio ^a,c  

^a UNIVERSITÉ DE NANTES   (France)

^b INSERM   (France)

^c NANTES UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; CD40IG ANTIGEN; CD45 ANTIGEN; CD45RC ANTIGEN; GAMMA INTERFERON; INDOLEAMINE 2,3 DIOXYGENASE; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG;

ADOPTIVE TRANSFER; ALLOGRAFT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CD8+ T LYMPHOCYTE; CELL SUBPOPULATION; CONTROLLED STUDY; GRAFT RECIPIENT; GRAFT REJECTION; GRAFT SURVIVAL; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SPLEEN CELL;

ADOPTIVE TRANSFER; ANIMALS; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNE TOLERANCE; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; INTERFERON TYPE II; RATS; RATS, INBRED LEW; RECOMBINANT FUSION PROTEINS; T-LYMPHOCYTES; TRANSPLANTATION, HOMOLOGOUS;

EID: 34147112868     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI28801     Document Type: Article

References (49)

1. Waldmann, H., and Cobbold, S. 2004. Exploiting tolerance processes in transplantation. Science. 305:209-212.
2. Wood, K.J., and Sakaguchi, S. 2003. Regulatory T cells in transplantation tolerance. Nat. Rev. Immunol. 3:199-210.
3. Xystrakis, E., et al. 2004. Identification of a novel natural regulatory CD8 T-cell subset and analysis of its mechanism of regulation. Blood. 104:3294-3301.
4. Liu, J., et al. 2004. Rat CD8+ FOXP3+ T suppressor cells mediate tolerance to allogeneic heart transplants, inducing PIR-B in APC and rendering the graft invulnerable to rejection. Transpl. Immunol. 13:239-247.
5. Zhou, J., Carr, R.I., Liwski, R.S., Stadnyk, A.W., and Lee, T.D. 2001. Oral exposure to alloantigen generates intragraft CD8+ regulatory cells. J. Immunol. 167:107-113.
6. Jiang, H., and Chess, L. 2000. The specific regulation of immune responses by CD8+ T cells restricted by the MHC class Ib molecule, Qa-1. Annu. Rev. Immunol. 18:185-216.
7. Dhodapkar, M.V., and Steinman, R.M. 2002. Antigen-bearing immature dendritic cells induce peptide-specific CD8(+) regulatory T cells in vivo in humans. Blood. 100:174-177.
8. Seo, S.K., et al. 2004. 4-1BB-mediated immunotherapy of rheumatoid arthritis. Nat. Med. 10:1088-1094.
9. + Tregs. J. Clin. Invest. 115:2904-2913. doi:10.1172/JCI23961.
10. Balashov, K.E., Khoury, S.J., Hafler, D.A., and Weiner, H.L. 1995. Inhibition of T cell responses by activated human CD8+ T cells is mediated by interferon-γ and is defective in chronic progressive multiple sclerosis. J. Clin. Invest. 95:2711-2719.
11. Chang, C., et al. 2002. Tolerization of dendritic cells by Ts cells: the crucial role of inhibitory ILT3 and ILT4. Nat. Immunol. 3:237-243.
12. - T cells in an autoimmune disease model. J. Clin. Invest. 112:1037-1048. doi:10.1172/JCI200317935.
13. Douillard, P., et al. 1996. Donor-specific blood transfusion induced tolerance in adult rats with a dominant TcR-Vb rearrangement in heart allografts. J. Immunol. 157:1250-1260.
14. Oluwole, S.F., Ng, A.K., Reemtsma, K., and Hardy, M.A. 1989. The mechanism of the induction of immunologic unresponsiveness to rat cardiac allografts by recipient pretreatment with donor lymphocyte subsets. Transplantation. 48:281-288.
15. Onodera, K.L., et al. 1999. Distinct tolerance pathways in sensitized allograft recipients after selective blockade of activation signal 1 or signal 2. Transplantation. 68:288-293.
16. Kataoka, M., Margenthaler, J.A., Ku, G., and Flye, M.W. 2003. Development of infectious tolerance after donor-specific transfusion and rat heart transplantation. J. Immunol. 171:204-211.
17. Larsen, C.P., et al. 1996. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature. 381:434-438.
18. Adams, A.B., et al. 2005. Development of a chimeric anti-CD40 monoclonal antibody that synergizes with LEA29Y to prolong islet allograft survival. J. Immunol. 174:542-550.
19. Guillot, C., et al. 2002. Prolonged blockade of CD40-CD40 ligand interactions by gene transfer of CD40Ig results in long-term heart allograft survival and donor-specific hyporesponsiveness, but does not prevent chronic rejection. J. Immunol. 168:1600-1609.
20. Quezada, S.A., Jarvinen, L.Z., Lind, E.F., and Noelle, R.J. 2004. CD40/CD154 interactions at the interface of tolerance and immunity. Annu. Rev. Immunol. 22:307-328.
21. Honey, K., Cobbold, S., and Waldmann, H. 1999. CD40 ligand blockade induces CD4+ T cell tolerance and linked suppression. J. Immunol. 163:4805-4810.
22. Monk, N.J., et al. 2003. Fc-dependent depletion of activated T cells occurs through CD40L-specific antibody rather than costimulation blockade. Nat. Med. 9:1275-1280.
23. Blair, P.J., et al. 2000. CD40 ligand (CD154) triggers a short-term CD4(+) T cell activation response that results in secretion of immunomodulatory cytokines and apoptosis. J. Exp. Med. 191:651-660.
24. Albert, M., Jegathesan, M., and Darnell, R. 2001. Dendritic cell maturation is required for the cross-tolerization of CD8+ cells. Nat. Immunol. 2:1010-1017.
25. Grohmann, U., et al. 2001. CD40 ligation ablates the tolerogenic potential of lymphoid dendritic cells. J. Immunol. 166:277-283.
26. Martin, E., O'Sullivan, B., Low, P., and Thomas, R. 2003. Antigen-specific suppression of a primed immune response by dendritic cells mediated by regulatory T cells secreting interleukin-10. Immunity. 18:155-167.
27. Homann, D., et al. 2002. CD40L blockade prevents autoimmune diabetes by induction of bitypic NK/DC regulatory cells. Immunity. 16:403-415.
28. Mellor, A.L., and Munn, D.H. 2004. IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nat. Rev. Immunol. 4:762-774.
29. Grohmann, U., et al. 2002. CTLA-4-Ig regulates tryptophan catabolism in vivo. Nat. Immunol. 3:1097-1101.
30. Graca, L., Honey, K., Adams, E., Cobbold, S., and Waldmann, H. 2000. Anti-CD154 therapeutic antibodies induce infectious transplantation tolerance. J. Immunol. 165:4783-4786.
31. Nomura, M., et al. 2002. Induction of donor-specific tolerance by adenovirus-mediated CD40Ig gene therapy in rat liver transplantation. Transplantation. 73:1403-1410.
32. Gregori, S., et al. 2001. Regulatory T cells induced by 1 alpha,25-dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance. J. Immunol. 167:1945-1953.
33. Chiffoleau, E., et al. 2002. Role for thymic and splenic regulatory CD4+ T cells induced by donor dendritic cells in allograft tolerance by LF15-0195 treatment. J. Immunol. 168:5058-5069.
34. Konieczny, B.T., et al. 1998. IFN-gamma is critical for long-term allograft survival induced by blocking the CD28 and CD40 ligand T cell costimulation pathways. J. Immunol. 160:2059-2064.
35. Sawitzki, B., et al. 2005. IFN-gamma production by alloantigen-reactive regulatory T cells is important for their regulatory function in vivo. J. Exp. Med. 201:1925-1935.
36. Tellides, G., et al. 2000. Interferon-gamma elicits arteriosclerosis in the absence of leukocytes. Nature. 403:207-211.
37. Shirasugi, N., et al. 2002. Prevention of chronic rejection in murine cardiac allografts: a comparison of chimerism- and nonchimerism-inducing costimulation blockade-based tolerance induction regimens. J. Immunol. 169:2677-2684.
38. Yamashita, K., et al. 2006. Heme oxygenase-1 is essential for and promotes tolerance to transplanted organs. FASEB J. 20:776-778.
39. Munn, D.H., et al. 2005. GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase. Immunity. 22:633-642.
40. Beutelspacher, S.C., et al. 2006. Expression of indoleamine 2,3-dioxygenase (IDO) by endothelial cells: implications for the control of alloresponses. Am. J. Transplant. 6:1320-1330.
41. Munn, D.H., and Mellor, A.L. 2004. IDO and tolerance to tumors. Trends Mol. Med. 10:15-18.
42. Lee, I., et al. 2005. Recruitment of Foxp3+ T regulatory cells mediating allograft tolerance depends on the CCR4 chemokine receptor. J. Exp. Med. 201:1037-1044.
43. Chen, Z., Herman, A.E., Matos, M., Mathis, D., and Benoist, C. 2005. Where CD4+CD25+ T reg cells impinge on autoimmune diabetes. J. Exp. Med. 202:1387-1397.
44. Waldmann, H., et al. 2004. Regulatory T cells and organ transplantation. Semin. Immunol. 16:119-126.
45. Huse, M., Lillemeier, B.F., Kuhns, M.S., Chen, D.S., and Davis, M.M. 2006. T cells use two directionally distinct pathways for cytokine secretion. Nat. Immunol. 7:247-255.
46. Braudeau, C., et al. 2004. Induction of long-term cardiac allograft survival by heme oxygenase-1 gene transfer. Gene Ther. 11:701-710.
47. Hill, M., et al. 2005. Heme oxygenase-1 inhibits rat and human breast cancer cells proliferation: mutual cross-inhibition with indoleamine 2,3-dioxygenase. FASEB J. 19:1957-1968.
48. Guillot, C., et al. 2000. Tolerance to cardiac allografts via local and systemic mechanisms after adenovirus-mediated CTLA4Ig expression. J. Immunol. 164:5258-5268.
49. Haspot, F., et al. 2005. Anti-CD28 antibody-induced kidney allograft tolerance related to tryptophan degradation and TCR class II B7 regulatory cells. Am. J. Transplant. 5:2339-2348.